The latest report by IMARC Group, titled “Europe Probiotic Supplements Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. The Europe probiotic supplements market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.63% during 2023-2028.

Probiotic supplements are the type of dietary products that include microorganisms as functional ingredients. These supplements are enriched with some common microorganisms such as Lactobacilli, Bifidobacterium, Streptococcus, Saccharomyces Boulardii, etc. As a result, probiotic supplements help in maintaining a healthy balance of gut microbiomes, boosting immunity, reducing inflammatory responses, improving mental health conditions, etc. These supplements are generally available in the forms of food supplements, infant formula, nutritional supplements, specialty nutrients, etc.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/europe-probiotic-supplements-market/requestsample

Europe Probiotic Supplements Market Trends and Drivers:

In Europe, the increasing prevalence of various chronic diseases, such as Gastroesophageal Reflux Disease (GERD), Crohn’s disease, gastroenteritis, etc., is primarily propelling the demand for probiotic supplements. Moreover, the escalating geriatric population, who are more prone to such ailments, is also bolstering the market growth in the region. Besides this, the gradual shift in consumer preferences from carbonated drinks towards functional and probiotic beverages is further providing a thrust to the market. Additionally, the launch of several innovative product variants in exotic flavors and attractive packaging is also catalyzing the sales of probiotic supplements in Europe. In the coming years, the changing consumer inclination from chemical additives-based supplements towards organic, natural, and clean-labeled alternatives, including probiotic supplements, will continue to propel the market growth in Europe.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Ingredient:

  • Bacteria
    • Lactobacilli
    • Bifidobacterium
    • Streptococcus
  • Yeast
    • Saccharomyces Boulardii
    • Others

Breakup by Form:

  • Powder
  • Tablet
  • Liquid
  • Others

Breakup by Application:

  • Food Supplements
  • Nutritional Supplements
  • Speciality Nutrients
  • Infant Formula
  • Others

Breakup by Distribution Channel:

  • Supermarkets and Hypermarkets
  • Hospitals & Clinics
  • Pharmacies
  • Online
  • Others

Breakup by Country:

  • Germany
  • France
  • United Kingdom
  • Russia
  • Italy
  • Spain
  • Others

Competitive Landscape with Key Player:

  • BioGaia
  • Bio-K Plus International Inc.
  • Chr. Hansen Holding A/S
  • Daflorn Probiotics UK
  • Danone S.A,
  • Exden
  • IPA EUROPE
  • PepsiCo Inc.
  • Vitafoods
  • Yakult Honsha.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: [email protected]

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal